September Nasdaq 100 E-Mini futures (NQU24) are trending down -0.06% this morning as market participants refrained from making big bets ahead of a highly anticipated earnings report from AI darling Nvidia.
In yesterday’s trading session, Wall Street’s main stock indexes closed in the green. ResMed (RMD) climbed over +7% and was the top percentage gainer on the S&P 500 after William Blair stated that the company sees the GLP-1 weight loss drug impact as a “tailwind” for its sleep apnea and CPAP business. Also, chip stocks gained ground, with Analog Devices (ADI) and Qualcomm (QCOM) rising more than +2%. In addition, Insulet (PODD) advanced over +6% after the medical device company obtained FDA approval for its Omnipod 5 automated insulin delivery system to treat individuals with Type 2 diabetes aged 18 and older. On the bearish side, Paramount Global (PARA) slumped more than -7% after media veteran Edgar Bronfman abandoned his bid to acquire the company.
